Literature DB >> 11438527

Crystal structure of human epidermal growth factor and its dimerization.

H S Lu1, J J Chai, M Li, B R Huang, C H He, R C Bi.   

Abstract

Epidermal growth factor (EGF) is a typical growth-stimulating peptide and functions by binding to specific cell-surface receptors and inducing dimerization of the receptors. Little is known about the molecular mechanism of EGF-induced dimerization of EGF receptors. The crystal structure of human EGF has been determined at pH 8.1. There are two human EGF molecules A and B in the asymmetric unit of the crystals, which form a potential dimer. Importantly, a number of residues known to be indispensable for EGF binding to its receptor are involved in the interface between the two EGF molecules, suggesting a crucial role of EGF dimerization in the EGF-induced dimerization of receptors. In addition, the crystal structure of EGF shares the main features of the NMR structure of mouse EGF determined at pH 2.0, but structural comparisons between different models have revealed new detailed features and properties of the EGF structure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11438527     DOI: 10.1074/jbc.M102874200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  EGFL6 promotes endothelial cell migration and angiogenesis through the activation of extracellular signal-regulated kinase.

Authors:  Shek Man Chim; An Qin; Jennifer Tickner; Nathan Pavlos; Tamara Davey; Hao Wang; Yajun Guo; Ming Hao Zheng; Jiake Xu
Journal:  J Biol Chem       Date:  2011-04-29       Impact factor: 5.157

2.  Structure of human C8 protein provides mechanistic insight into membrane pore formation by complement.

Authors:  Leslie L Lovelace; Christopher L Cooper; James M Sodetz; Lukasz Lebioda
Journal:  J Biol Chem       Date:  2011-03-25       Impact factor: 5.157

3.  Increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 activity in response to EGFR signaling contributes to non-small cell lung cancer cell survival.

Authors:  Nadiia Lypova; Sucheta Telang; Jason Chesney; Yoannis Imbert-Fernandez
Journal:  J Biol Chem       Date:  2019-05-24       Impact factor: 5.157

4.  Temperature-induced unfolding of epidermal growth factor (EGF): insight from molecular dynamics simulation.

Authors:  Chunli Yan; Varun Pattani; James W Tunnell; Pengyu Ren
Journal:  J Mol Graph Model       Date:  2010-04-04       Impact factor: 2.518

5.  Ligand Density and Nanoparticle Clustering Cooperate in the Multivalent Amplification of Epidermal Growth Factor Receptor Activation.

Authors:  Qianyun Zhang; Björn M Reinhard
Journal:  ACS Nano       Date:  2018-10-11       Impact factor: 15.881

6.  The emerging role of nimotuzumab in the treatment of non-small cell lung cancer.

Authors:  William Boland; Gwyn Bebb
Journal:  Biologics       Date:  2010-11-09

7.  Structural basis for EGFR ligand sequestration by Argos.

Authors:  Daryl E Klein; Steven E Stayrook; Fumin Shi; Kartik Narayan; Mark A Lemmon
Journal:  Nature       Date:  2008-05-25       Impact factor: 49.962

8.  Mutation of fibulin-1 causes a novel syndrome involving the central nervous system and connective tissues.

Authors:  Saeed Bohlega; Huda Al-Ajlan; Amr Al-Saif
Journal:  Eur J Hum Genet       Date:  2013-10-02       Impact factor: 4.246

9.  Extraction of PLGA-microencapsulated proteins using a two-immiscible liquid phases system containing surfactants.

Authors:  Vivian Saez; José A Ramón; Liurdis Caballero; Raymersy Aldana; Elián Cruz; Carlos Peniche; Rolando Paez
Journal:  Pharm Res       Date:  2012-11-08       Impact factor: 4.200

10.  Mutations in multidomain protein MEGF8 identify a Carpenter syndrome subtype associated with defective lateralization.

Authors:  Stephen R F Twigg; Deborah Lloyd; Dagan Jenkins; Nursel E Elçioglu; Christopher D O Cooper; Nouriya Al-Sannaa; Ali Annagür; Gabriele Gillessen-Kaesbach; Irina Hüning; Samantha J L Knight; Judith A Goodship; Bernard D Keavney; Philip L Beales; Opher Gileadi; Simon J McGowan; Andrew O M Wilkie
Journal:  Am J Hum Genet       Date:  2012-10-11       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.